# BYND — local-model

## Metadata

ticker: BYND
arm: local-model
judge_prompt_version: v2
context_sha256: 4177d38279b28d803af26b0a8c03b83d902a67ca2e6b3f140713c47d0ff0f0da
local_model_served_name: qwen2.5-1.5b-instruct
local_model_dir: qwen2.5-1.5b-instruct
local_model_backend: openai
local_model_url: http://vllm.financial-agent.svc:8000
local_model_sampling: {"max_tokens": 512, "min_p": 0.0, "repetition_penalty": 1.1, "temperature": 0.1, "top_k": 20, "top_p": 0.8}

## Retrieved source context

STOCK DATA:
{
  "ticker": "BYND",
  "company_name": "Beyond Meat, Inc.",
  "current_price": 10.03,
  "currency": "USD",
  "market_cap": 172455456.0,
  "forward_pe": -0.96216565,
  "week_52_high": 230.7,
  "week_52_low": 9.81,
  "revenue": 258844992.0,
  "net_income": 258864992.0,
  "profit_margin": 1.15852,
  "sector": "Consumer Defensive",
  "industry": "Packaged Foods"
}

NEWS ARTICLES:
[]

SEC FILING SUMMARIES:
{
  "10-K": {
    "form_type": "10-K",
    "filing_date": "2026-04-09",
    "summary": "ITEM 1A. RISK FACTORS. Risk Factor Summary We are providing the following summary of the risk factors to enhance the readability and accessibility of our risk factor disclosures. We encourage you to carefully review the full risk factors immediately following this summary as well as the other information in this report, including Item 7 , Management\u2019s Discussion and Analysis of Financial Condition and Results of Operations , Note Regarding Forward-Looking Statements , and our consolidated financial statements and related notes, before deciding whether to invest in shares of our common stock. The risks and uncertainties described in this report may not be the only ones we face. If any of the risks actually occurs, our business, financial condition, operating results, cash flows and prospect"
  },
  "10-Q": {
    "form_type": "10-Q",
    "filing_date": "2026-08-06",
    "summary": "ITEM 1A. RISK FACTORS. In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, Item 1A, Risk Factors, in our 2025 10-K, as updated and supplemented below and in our subsequent filings. These risks could materially harm our business, operating results and financial condition. Additional factors and uncertainties not currently known to us or that we currently consider immaterial also may materially adversely affect our business, financial condition or future results. Risk Factors Risks Related to Our Business Our strategic repositioning to \u201cBeyond The Plant Protein Company\u201d may not be successful, and our failure to effectively execute or realize the anticipated benefits of this strategy could have a material adverse effect"
  }
}

RAG — SEC HIGHLIGHTS:
[From Pinecone cache] I cannot provide a summary of the latest 10-K and 10-Q based on the information provided. The context materials only contain risk factor disclosures from SEC filings for Beyond Meat (BYND), which represent just one section of these comprehensive documents.

To properly summarize the key takeaways from a 10-K or 10-Q, I would need access to additional sections such as:

- Management's Discussion and Analysis (MD&A)
- Financial statements and results of operations
- Business overview and strategy
- Executive compensation
- Market data and performance metrics
- Cash flow information
- Balance sheet details

The risk factors alone do not provide a complete picture of the company's financial performance, operational results, or overall business status. If you'd like information about the specific risks facing the company, I can help with that based on the materials provided. Otherwise, I would recommend reviewing the complete 10-K or 10-Q filing directly for a comprehensive understanding of the company's latest financial and operational performance.

RAG — RISK FACTORS:
[From Pinecone cache] # Primary Risk Factors Disclosed

The company discloses risk factors across three main categories:

## Risks Related to Business Operations
- Adverse economic and political conditions, including inflation concerns, government shutdowns, and trade policy uncertainties
- History of losses and negative cash flows, with challenges in achieving sustained profitability
- Weakness in the plant-based meat category with ongoing demand declines
- Operational challenges including cost-reduction initiatives, workforce reductions, and leadership changes
- Demand forecasting and capacity utilization difficulties
- Inventory management challenges, including potential liquidation at lower prices
- Supply chain disruptions and reliance on limited third-party suppliers
- Limited distributor base and customer consolidation risks
- Co-manufacturing dependencies and facility disruption risks
- Revenue growth challenges and seasonal fluctuations
- Talent retention and labor relations concerns
- Geopolitical tensions affecting supply chains, costs, and market access

## Risks Related to Products
- Food safety incidents and product misbranding concerns
- Declining sales of flagship products
- Changing consumer preferences and trends
- Challenges in new product introduction and improvement
- Price volatility of ingredients and packaging materials

## Risks Related to Industry and Brand
- Increased competition and new market entrants
- Consumer reaction to product changes
- Brand reputation damage from quality or health issues
- Challenges in brand development and maintenance

## Pre-written sections (judge input)

### Financial Health

#### Key Metrics:

- **Price**: $10.03 per share
- **Market Cap**: $1.72 billion
- **P/E Ratio**: -0.96 (negative value indicates lower valuation)
- **Revenue**: $258.84 million
- **Net Income**: $258.86 million
- **Profit Margin**: 115.85%

#### Brief Financial Assessment:

Beyond Meat, Inc., represented by its ticker BYND, operates within the Consumer Defensive sector and falls under the Packaged Foods industry. As of the latest data available, the company's current price is $10.03 per share, reflecting a market capitalization of $1.72 billion. Despite the negative P/E ratio (-0.96), indicating potentially undervalued stock, the company has demonstrated strong profitability with net income exceeding revenues at 115.85%. This robust performance suggests that Beyond Meat is likely positioned for sustained growth despite the challenging economic environment. However, investors should remain vigilant given the company’s recent SEC filing highlighting potential risks associated with its strategic shift towards becoming a “Beyond The Plant Protein Company.”

### Recent Developments

Beyond Meat's most recent SEC filings reveal significant strategic repositioning challenges, with the company's 2026 10-Q highlighting risks related to its shift toward becoming "Beyond The Plant Protein Company." The company's financial metrics show concerning trends, including a negative forward P/E ratio and a dramatic stock decline from a 52-week high of $230.70 to $10.03, reflecting investor skepticism about execution. With a market cap of approximately $172 million and minimal profitability despite $259 million in revenue, Beyond Meat faces substantial pressure to demonstrate the viability of its strategic repositioning and return to sustainable growth. The company's risk disclosures emphasize uncertainty around whether anticipated benefits from this strategy will materialize, suggesting management acknowledges execution risks that could further impact shareholder value.

### SEC Filing Highlights

Unable to provide accurate SEC filing highlights at this time. The available source materials contain only risk factor disclosures from Beyond Meat's SEC filings, which represent a limited portion of the complete 10-K or 10-Q documents. A comprehensive summary of key takeaways requires access to additional critical sections including Management's Discussion and Analysis (MD&A), financial statements, results of operations, and cash flow information. For complete and accurate filing highlights, please consult Beyond Meat's most recent 10-K or 10-Q filing directly on the SEC's EDGAR database.

### Risk Factors

1. **Adverse Economic and Political Conditions**: Fluctuations in global markets can impact Beyond Meat's operations, leading to increased costs and reduced revenue.
   
2. **History of Losses and Negative Cash Flows**: The company faces ongoing challenges in achieving sustained profitability due to operational inefficiencies and strategic decisions that may not yield immediate returns.

## Audited (Exec Summary + Outlook)

### Executive Summary
Beyond Meat, Inc. is a packaged foods company operating within the Consumer Defensive sector that has staked its identity on plant-based protein products, generating $258.84 million in revenue while trading at $10.03 per share against a market capitalization of $1.72 billion. The stock is notable now because it has fallen dramatically from a 52-week high of $230.70 to its current price, reflecting deep investor skepticism about the company's ability to execute a significant strategic repositioning toward becoming the "Beyond The Plant Protein Company" — a pivot that management itself has flagged as carrying material execution risk. The single most important near-term variable is whether Beyond Meat can demonstrate credible, tangible progress on this strategic shift in a way that rebuilds confidence that the anticipated benefits will actually materialize.

### Outlook
The directional lean on Beyond Meat is **cautious**. The headwinds are substantial and well-documented: a history of losses and negative cash flows, a stock that has shed the overwhelming majority of its value from its 52-week high, adverse global economic and political conditions that pressure input costs and consumer spending, and a strategic repositioning whose benefits management itself has characterized as uncertain. The primary tailwind is the possibility that the pivot toward a broader plant-protein identity could unlock new revenue streams and consumer segments if executed effectively — but that remains an open question rather than a demonstrated reality. Investors should watch the following key variables closely: the pace and coherence of the "Beyond The Plant Protein Company" strategy as it is communicated in successive SEC filings and earnings disclosures; whether cash flow trends show meaningful improvement or continued deterioration; how consumer demand for plant-based products evolves in the broader packaged foods category; and whether management's operational decisions begin to close the gap between strategic ambition and financial results. What would improve this view is clear evidence of strategic execution — sustained revenue momentum, a credible path toward positive cash flow, and reduced risk-factor language around the repositioning in future filings. What would further weaken it is continued operational inefficiency, deepening losses, or additional signals from management that the strategic transition is stalling.

---
*This brief is for informational purposes only and does not constitute financial advice.*

## Judge findings

I will now systematically audit every specific quantitative figure, price target, threshold, ratio, metric, percentage, named product milestone, or forward-looking number in the Executive Summary and Outlook sections.

---

**EXECUTIVE SUMMARY**

---

CLAIM: "generating $258.84 million in revenue"
LABEL: SUPPORTED
REASON: The raw source data lists revenue as $258,844,992.0, which rounds to $258.84 million, and the pre-written Financial Health section also states "Revenue: $258.84 million."

---

CLAIM: "trading at $10.03 per share"
LABEL: SUPPORTED
REASON: The raw source data explicitly lists current_price as 10.03 USD, confirmed in the pre-written Financial Health section.

---

CLAIM: "market capitalization of $1.72 billion"
LABEL: UNSUPPORTED
REASON: The raw source data lists market_cap as $172,455,456.0, which is approximately $172 million, not $1.72 billion; the pre-written Financial Health section incorrectly states "$1.72 billion" but the Recent Developments section correctly states "approximately $172 million," and the raw data confirms the figure is ~$172 million, making the $1.72 billion claim off by a factor of 10.

---

CLAIM: "fallen dramatically from a 52-week high of $230.70 to its current price"
LABEL: SUPPORTED
REASON: The raw source data lists week_52_high as 230.7 and current_price as 10.03, confirming both figures and the directional claim.

---

**OUTLOOK**

---

CLAIM: "a stock that has shed the overwhelming majority of its value from its 52-week high"
LABEL: SUPPORTED
REASON: Computing the decline: (230.70 − 10.03) / 230.70 = 95.65% decline, which arithmetically confirms the stock has shed the overwhelming majority of its value from its 52-week high.

---

*(No additional specific quantitative figures, price targets, thresholds, ratios, metrics, percentages, named product milestones, or forward-looking numbers appear in the Outlook section beyond the directional and qualitative statements already covered or the 52-week high reference already audited above.)*

---

**SUMMARY OF FINDINGS**

| Claim | Label |
|---|---|
| $258.84 million in revenue | SUPPORTED |
| $10.03 per share | SUPPORTED |
| Market capitalization of $1.72 billion | UNSUPPORTED |
| 52-week high of $230.70 | SUPPORTED |
| Stock shed the overwhelming majority of its value from 52-week high | SUPPORTED |

**Critical finding:** The market capitalization figure of "$1.72 billion" in the Executive Summary is materially incorrect. The raw source data shows a market cap of $172,455,456 (~$172 million). The error originates in the pre-written Financial Health section and was propagated into the Executive Summary. Notably, the pre-written Recent Developments section correctly identified the market cap as "approximately $172 million," meaning the synthesis model selected the erroneous figure from the Financial Health section rather than the correct one from Recent Developments.
